α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease
John Magenau(University of Michigan), Pavan Reddy(Wichita State University), Charles A. Dinarello(University of Colorado Anschutz Medical Campus), Corey Cutler(Harvard University), John Koreth(Otsuka (Japan)), Vincent T. Ho(Dana-Farber Cancer Institute), Mary Riwes(University of Michigan), Joseph H. Antin(Dana-Farber Cancer Institute), Sung Won Choi(University of Michigan), Eli C. Lewis(Ben-Gurion University of the Negev), Robert J. Soiffer(Dana-Farber Cancer Institute), Maggi Kennel(University of Michigan), Edwin P. Alyea(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Gregory A. Yanik(University of Michigan), Brian Parkin(AdventHealth Orlando), Thomas Braun(University of Michigan), Dan Peltier(University of Michigan), Steven C. Goldstein(University of Michigan), Attaphol Pawarode(University of Michigan)
Cited by 115
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
|New England Journal of Medicine|2011|1.1k